how long are semaglutide vials good for in Winter Garden how long does vial of
Description
Semaglutide 2.4 mg once weekly is the latest approved GLP-1 RA for obesity management (2021) and results in 1517% mean WL through appetite reduction [11, 12]

N Engl J Med.2021;384(11):989-1002

Superior Weight-Loss Efficacy Versus Other GLP-1 RAs Wegovy achieved a 15.8% mean weight loss in the STEP 1 trial, whereas tirzepatide posted a 22.5% mean weight loss, prompting U.S
Accessed 27 Sept 2024

Now that you have clarity on eligibility and how to access Wegovy in the UK, you're well-prepared to consider this weight management option if you meet the criteria

Depending on the makeup of their patient base, providers may need to navigate patient therapy discontinuation and a change in payer mix that could impact revenue
